Agape ATP Corporation (ATPC) 10-Year Financial Performance & Capital Metrics

ATPC • • Industrial / General

Consumer DefensivePackaged FoodsNutritional Supplements & WellnessDietary Supplements & Vitamins

AboutAgape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.Show more

Revenue $1M -7.6%
EBITDA -$2M -22.0%
Net Income -$2M -17.5%
EPS (Diluted) -0.63 -2174.4%
Gross Margin 57.39% -12.3%
EBITDA Margin -177.41% -32.0%
Operating Margin -194.55% -29.7%
Net Margin -186.77% -27.2%
ROE -78.3% -10.7%
ROIC -1623.38% +2.8%
Debt/Equity 0.19 +88.2%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Share count reduced 16.3% through buybacks

✗Weaknesses

✗Weak Piotroski F-Score: 2/9
✗Negative free cash flow
✗Weak momentum: RS Rating 0 (bottom 0%)
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y9.02%

3Y9.16%

TTM9.66%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-3.07%

EPS CAGR

10Y-

5Y-

3Y-

TTM-154.94%

ROCE

10Y Avg-31.95%

5Y Avg-49.62%

3Y Avg-68.76%

Latest-75.77%

Peer Comparison

Dietary Supplements & Vitamins

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
SMPLThe Simply Good Foods Company	1.96B	21.15	20.74	8.98%	6.26%	5.23%	8.07%	0.17
FTLFFitLife Brands, Inc.	146.88M	15.64	17.23	22.33%	9.57%	16.13%	6.54%	0.37
USNAUSANA Health Sciences, Inc.	394.87M	21.60	9.86	-7.22%	1.86%	2.93%	12.9%	0.07
LFVNLifeVantage Corporation	80.4M	6.33	8.33	14.17%	4.78%	34.53%	13.07%	0.34
HLFHerbalife Nutrition Ltd.	1.72B	16.68	6.67	-1.37%	6.47%		9.48%
ATPCAgape ATP Corporation	5.45M	0.11	-0.17	-7.57%	-183%	-11.92%		0.19
HCWCHealthy Choice Wellness Corp.	5.38M	0.30	-0.62	24.57%	-5.44%	-73.95%		10.72

Profit & Loss

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	0	0	487K	1.55M	858.72K	3.45M	1.02M	1.86M	1.43M	1.32M
Revenue Growth %	-	-	-	2.17%	-0.44%	3.02%	-0.71%	0.83%	-0.23%	-0.08%
Cost of Goods Sold+	0	0	441.41K	1.44M	766.96K	775.86K	297.33K	666.04K	494.52K	563.6K
COGS % of Revenue	-	-	0.91%	0.93%	0.89%	0.22%	0.29%	0.36%	0.35%	0.43%
Gross Profit+	0	0	45.6K	109.35K	91.77K	2.68M	719.63K	1.19M	936.57K	759.15K
Gross Margin %	-	-	0.09%	0.07%	0.11%	0.78%	0.71%	0.64%	0.65%	0.57%
Gross Profit Growth %	-	-	-	1.4%	-0.16%	28.17%	-0.73%	0.65%	-0.21%	-0.19%
Operating Expenses+	300K	75.36K	276.47K	607.36K	624.54K	2.83M	2.58M	2.72M	3.08M	3.33M
OpEx % of Revenue	-	-	0.57%	0.39%	0.73%	0.82%	2.54%	1.47%	2.15%	2.52%
Selling, General & Admin	300K	75.36K	265.68K	607.36K	624.54K	2.83M	2.46M	2.72M	3.08M	3.33M
SG&A % of Revenue	-	-	0.55%	0.39%	0.73%	0.82%	2.42%	1.47%	2.15%	2.52%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	-14K	0	0	0	121.51K	0	0	0
Operating Income+	-300K	-75.36K	-366.96K	-514.51K	-532.77K	-158.13K	-1.86M	-1.53M	-2.15M	-2.57M
Operating Margin %	-	-	-0.75%	-0.33%	-0.62%	-0.05%	-1.83%	-0.83%	-1.5%	-1.95%
Operating Income Growth %	-	0.75%	-3.87%	-0.4%	-0.04%	0.7%	-10.75%	0.18%	-0.4%	-0.2%
EBITDA+	0	0	-132.88K	-353.37K	-677.87K	5.34K	-1.64M	-1.32M	-1.92M	-2.35M
EBITDA Margin %	-	-	-0.27%	-0.23%	-0.79%	0%	-1.61%	-0.71%	-1.34%	-1.77%
EBITDA Growth %	-	-	-	-1.66%	-0.92%	1.01%	-308.49%	0.2%	-0.46%	-0.22%
D&A (Non-Cash Add-back)	300K	75.36K	234.09K	161.14K	0	163.47K	217.21K	217.94K	223.19K	226.65K
EBIT	0	0	-234.09K	-131.17K	-677.87K	-158.13K	-1.86M	-1.53M	-2.15M	-2.57M
Net Interest Income+	0	0	0	0	0	0	25.57K	16.19K	29.25K	67.93K
Interest Income	0	0	0	0	0	0	25.57K	16.19K	29.25K	67.93K
Interest Expense	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	0	0	109.15K	-5.13K	-145.09K	674.48K	-529.04K	-136.87K	40.22K	92.23K
Pretax Income+	-300K	-75.36K	-124.94K	-519.64K	-677.86K	516.35K	-2.39M	-1.67M	-2.11M	-2.48M
Pretax Margin %	-	-	-0.26%	-0.34%	-0.79%	0.15%	-2.35%	-0.9%	-1.47%	-1.88%
Income Tax+	0	0	5.33K	0	0	161.58K	137.07K	-4.05K	3.58K	4.93K
Effective Tax Rate %	1%	1%	1.04%	1%	1%	0.69%	1.06%	1.01%	1%	1%
Net Income+	-300K	-75.36K	-130.27K	-519.64K	-677.86K	354.77K	-2.52M	-1.69M	-2.1M	-2.47M
Net Margin %	-	-	-0.27%	-0.34%	-0.79%	0.1%	-2.48%	-0.91%	-1.47%	-1.87%
Net Income Growth %	-	0.75%	-0.73%	-2.99%	-0.3%	1.52%	-8.12%	0.33%	-0.25%	-0.18%
Net Income (Continuing)	-300K	-75.36K	-130.27K	-519.64K	-677.86K	354.77K	-2.52M	-1.67M	-2.11M	-2.49M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	-336	20.51K	11.78K	-3.79K
EPS (Diluted)+	-0.00	-0.00	-0.00	-0.00	-0.00	0.00	-0.01	-0.02	-0.03	-0.63
EPS Growth %	-	-	-	-	-	-	-	-	-0.44%	-21.74%
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.00	0.00	-0.01	-0.02	-0.03	-0.63
Diluted Shares Outstanding	376.28M	376.28M	376.28M	376.28M	376.32M	376.39M	376.22M	87.82M	75.81M	63.49M
Basic Shares Outstanding	376.28M	376.28M	373.28M	376.28M	376.32M	376.39M	376.22M	87.82M	75.85M	63.49M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	10	2.31M	2.71M	3.79M	3.54M	5.68M	3.91M	2.03M	5.19M	2.78M
Cash & Short-Term Investments	10	2.31M	1.86M	2.86M	2.74M	3.52M	2.6M	1.44M	4.83M	2.04M
Cash Only	10	2.31M	1.86M	2.86M	238.94K	3.52M	622.5K	1.44M	4.83M	2.04M
Short-Term Investments	0	0	0	0	2.51M	0	1.98M	0	0	0
Accounts Receivable	0	0	489.84K	435.55K	523K	175.99K	1.29K	17.9K	66.99K	58.51K
Days Sales Outstanding	-	-	367.12	102.83	222.3	18.61	0.46	3.52	17.08	16.14
Inventory	0	0	0	0	0	589.81K	676.77K	46.28K	47.91K	46.35K
Days Inventory Outstanding	-	-	-	-	-	277.48	830.79	25.36	35.36	30.02
Other Current Assets	0	0	0	0	269.19K	0	0	0	0	0
Total Non-Current Assets+	0	0	1.33M	860.28K	798.62K	1.53M	812.41K	763.22K	559.34K	463.32K
Property, Plant & Equipment	0	0	0	0	0	692.45K	453.52K	223.28K	521.49K	435.01K
Fixed Asset Turnover	-	-	-	-	-	4.99x	2.24x	8.31x	2.74x	3.04x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	5.83K	3.66K	24.04K	17.46K	13.08K
Long-Term Investments	0	0	1.33M	860.28K	798.62K	578.53K	90.5K	16.69K	20.17K	15.24K
Other Non-Current Assets	0	0	0	0	0	249.53K	264.74K	499.2K	0	0
Total Assets+	10	2.31M	5.13M	4.65M	4.34M	7.21M	4.72M	2.79M	5.74M	3.24M
Asset Turnover	-	-	0.09x	0.33x	0.20x	0.48x	0.22x	0.67x	0.25x	0.41x
Asset Growth %	-	231273.8%	1.22%	-0.09%	-0.07%	0.66%	-0.34%	-0.41%	1.06%	-0.44%
Total Current Liabilities+	25K	8.1K	144.29K	71.4K	83.99K	1.04M	1.31M	1.23M	1.07M	1.12M
Accounts Payable	0	0	0	0	2.79K	0	13.71K	28.83K	90.43K	102.8K
Days Payables Outstanding	-	-	-	-	1.33	-	16.84	15.8	66.75	66.57
Short-Term Debt	0	0	0	0	3.95K	0	0	0	0	0
Deferred Revenue (Current)	0	0	0	0	0	236.13K	279.69K	363.02K	101.58K	96.98K
Other Current Liabilities	25K	0	7.19K	0	77.25K	0	0	-384.38K	0	0
Current Ratio	0.00x	285.52x	18.77x	53.10x	42.11x	5.47x	2.98x	1.65x	4.84x	2.48x
Quick Ratio	0.00x	285.52x	18.77x	53.10x	42.11x	4.91x	2.46x	1.61x	4.79x	2.44x
Cash Conversion Cycle	-	-	-	-	-	-	814.41	13.08	-14.3	-20.41
Total Non-Current Liabilities+	0	0	0	0	0	247.23K	99.06K	0	292.09K	190.78K
Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	241.49K	83.48K	0	292.09K	190.78K
Deferred Tax Liabilities	0	0	0	0	0	5.74K	15.57K	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0	0	0	0
Total Liabilities	25K	8.1K	144.29K	71.4K	83.99K	1.29M	1.41M	1.23M	1.36M	1.31M
Total Debt+	0	100	0	0	3.95K	395.76K	240.58K	82.71K	437.72K	362.78K
Net Debt	-10	-2.31M	-1.86M	-2.86M	-234.99K	-3.12M	-381.92K	-1.36M	-4.39M	-1.68M
Debt / Equity	-	0.00x	-	-	0.00x	0.07x	0.07x	0.05x	0.10x	0.19x
Debt / EBITDA	-	-	-	-	-	74.14x	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-584.83x	-	-	-	-
Interest Coverage	-	-	-	-	-	-	-	-	-	-
Total Equity+	-24.99K	2.3M	2.56M	4.58M	4.25M	5.92M	3.31M	1.56M	4.38M	1.93M
Equity Growth %	-	93.22%	0.11%	0.79%	-0.07%	0.39%	-0.44%	-0.53%	1.8%	-0.56%
Book Value per Share	-0.00	0.01	0.01	0.01	0.01	0.02	0.01	0.02	0.06	0.03
Total Shareholders' Equity	-24.99K	2.3M	2.56M	4.58M	4.25M	5.92M	3.31M	1.54M	4.37M	1.93M
Common Stock	10	37.13K	37.18K	37.63K	37.63K	37.65K	29.05K	7.54K	7.71K	399
Retained Earnings	-25K	-100.36K	-279.04K	-750.28K	-1.09M	-734.44K	-3.26M	-4.95M	-7.05M	-9.52M
Treasury Stock	0	0	0	0	0	0	0	0	-14	0
Accumulated OCI	0	0	3.74K	-79	9.79K	181.02K	93.4K	9.27K	30.21K	27.85K
Minority Interest	0	0	0	0	0	0	-336	20.51K	11.78K	-3.79K

Cash Flow

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	0	-100.26K	-347.98K	-667.06K	-113.94K	-557.95K	-845.84K	-811.68K	-2M	-2.73M
Operating CF Margin %	-	-	-0.71%	-0.43%	-0.13%	-0.16%	-0.83%	-0.44%	-1.4%	-2.06%
Operating CF Growth %	-	-	-2.47%	-0.92%	0.83%	-3.9%	-0.52%	0.04%	-1.47%	-0.36%
Net Income	-300K	-75.36K	-130.27K	-519.64K	-677.86K	354.77K	-2.52M	-1.67M	-2.11M	-2.49M
Depreciation & Amortization	0	0	0	0	0	163.47K	217.21K	217.94K	223.19K	226.65K
Stock-Based Compensation	0	0	0	0	0	0	0	0	0	0
Deferred Taxes	0	0	0	0	0	178.33K	10.13K	-14.75K	-220	220
Other Non-Cash Items	0	0	30.16K	474.55K	525.23K	-510.2K	644.05K	78.83K	24.71K	110.69K
Working Capital Changes	300K	-24.9K	-247.86K	-621.97K	156.59K	-744.32K	807.46K	572.38K	-139.57K	-577.74K
Change in Receivables	0	0	0	-511.61K	-85.6K	-167.57K	167.57K	21K	-45.67K	-21.51K
Change in Inventory	0	0	0	0	0	78.67K	192.71K	343.48K	-3.22K	-4.22K
Change in Payables	0	0	0	35.15K	-32.31K	-2.8K	0	41.42K	38.46K	39.55K
Cash from Investing+	0	0	-1.36M	-2.5K	-1.5K	1.28M	-3.96K	-32.12K	-17.25K	-50.05K
Capital Expenditures	0	0	0	0	0	-4.73K	-3.96K	-9.43K	-52.32K	-50.16K
CapEx % of Revenue	-	-	-	-	-	0%	0%	0.01%	0.04%	0.04%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	-1.36M	0	-1.5K	-178	0	-22.69K	35.07K	112
Cash from Financing+	120	2.41M	2.93M	-5.32K	-4.57K	-22.09K	-19.06K	-234.47K	5.4M	-11.86K
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	120	-2.36M	-2.92M	-5.32K	-4.57K	-22.09K	-19.06K	-234.47K	0	0
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	0	-100.26K	-347.98K	-667.06K	-113.94K	-562.86K	-849.8K	-843.8K	-2.05M	-2.78M
FCF Margin %	-	-	-0.71%	-0.43%	-0.13%	-0.16%	-0.84%	-0.45%	-1.44%	-2.1%
FCF Growth %	-	-	-2.47%	-0.92%	0.83%	-3.94%	-0.51%	0.01%	-1.43%	-0.35%
FCF per Share	-	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.01	-0.03	-0.04
FCF Conversion (FCF/Net Income)	-	1.33x	2.67x	1.28x	0.17x	-1.57x	0.34x	0.48x	0.95x	1.10x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	288.93K	326.84K	78.51K	34.84K	24K

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-6.61%	-5.35%	-14.55%	-15.35%	6.97%	-54.65%	-69.2%	-70.73%	-78.3%
Return on Invested Capital (ROIC)	-	-	-78.85%	-31.78%	-13.92%	-3.48%	-48.62%	-73.3%	-1669.61%	-1623.38%
Gross Margin	-	-	9.36%	7.07%	10.69%	77.53%	70.76%	64.13%	65.44%	57.39%
Net Margin	-	-	-26.75%	-33.61%	-78.94%	10.28%	-248.21%	-90.86%	-146.88%	-186.77%
Debt / Equity	-	0.00x	-	-	0.00x	0.07x	0.07x	0.05x	0.10x	0.19x
FCF Conversion	-	1.33x	2.67x	1.28x	0.17x	-1.57x	0.34x	0.48x	0.95x	1.10x
Revenue Growth	-	-	-	217.46%	-44.46%	302.06%	-70.55%	82.56%	-22.92%	-7.57%

Revenue by Segment

	2024
Product Health Therapies	913.3K
Product Health Therapies Growth	-
Health and Wellness Services	207.55K
Health and Wellness Services Growth	-
Energized Mineral Concentrate	43.49K
Energized Mineral Concentrate Growth	-
Ionized Cal Mag	388
Ionized Cal Mag Growth	-

Frequently Asked Questions

Growth & Financials

Agape ATP Corporation (ATPC) reported $1.5M in revenue for fiscal year 2024.

Agape ATP Corporation (ATPC) saw revenue decline by 7.6% over the past year.

Agape ATP Corporation (ATPC) reported a net loss of $2.7M for fiscal year 2024.

Dividend & Returns

Agape ATP Corporation (ATPC) has a return on equity (ROE) of -78.3%. Negative ROE indicates the company is unprofitable.

Agape ATP Corporation (ATPC) had negative free cash flow of $2.9M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Agape ATP Corporation (ATPC) 10-Year Financial Performance & Capital Metrics

ATPC • • Industrial / General

Consumer DefensivePackaged FoodsNutritional Supplements & WellnessDietary Supplements & Vitamins

Revenue $1M -7.6%
EBITDA -$2M -22.0%
Net Income -$2M -17.5%
EPS (Diluted) -0.63 -2174.4%
Gross Margin 57.39% -12.3%
EBITDA Margin -177.41% -32.0%
Operating Margin -194.55% -29.7%
Net Margin -186.77% -27.2%
ROE -78.3% -10.7%
ROIC -1623.38% +2.8%
Debt/Equity 0.19 +88.2%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Share count reduced 16.3% through buybacks

✗Weaknesses

✗Weak Piotroski F-Score: 2/9
✗Negative free cash flow
✗Weak momentum: RS Rating 0 (bottom 0%)
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y9.02%

3Y9.16%

TTM9.66%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-3.07%

EPS CAGR

10Y-

5Y-

3Y-

TTM-154.94%

ROCE

10Y Avg-31.95%

5Y Avg-49.62%

3Y Avg-68.76%

Latest-75.77%

Peer Comparison

Dietary Supplements & Vitamins

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
SMPLThe Simply Good Foods Company	1.96B	21.15	20.74	8.98%	6.26%	5.23%	8.07%	0.17
FTLFFitLife Brands, Inc.	146.88M	15.64	17.23	22.33%	9.57%	16.13%	6.54%	0.37
USNAUSANA Health Sciences, Inc.	394.87M	21.60	9.86	-7.22%	1.86%	2.93%	12.9%	0.07
LFVNLifeVantage Corporation	80.4M	6.33	8.33	14.17%	4.78%	34.53%	13.07%	0.34
HLFHerbalife Nutrition Ltd.	1.72B	16.68	6.67	-1.37%	6.47%		9.48%
ATPCAgape ATP Corporation	5.45M	0.11	-0.17	-7.57%	-183%	-11.92%		0.19
HCWCHealthy Choice Wellness Corp.	5.38M	0.30	-0.62	24.57%	-5.44%	-73.95%		10.72

Profit & Loss

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	0	0	487K	1.55M	858.72K	3.45M	1.02M	1.86M	1.43M	1.32M
Revenue Growth %	-	-	-	2.17%	-0.44%	3.02%	-0.71%	0.83%	-0.23%	-0.08%
Cost of Goods Sold+	0	0	441.41K	1.44M	766.96K	775.86K	297.33K	666.04K	494.52K	563.6K
COGS % of Revenue	-	-	0.91%	0.93%	0.89%	0.22%	0.29%	0.36%	0.35%	0.43%
Gross Profit+	0	0	45.6K	109.35K	91.77K	2.68M	719.63K	1.19M	936.57K	759.15K
Gross Margin %	-	-	0.09%	0.07%	0.11%	0.78%	0.71%	0.64%	0.65%	0.57%
Gross Profit Growth %	-	-	-	1.4%	-0.16%	28.17%	-0.73%	0.65%	-0.21%	-0.19%
Operating Expenses+	300K	75.36K	276.47K	607.36K	624.54K	2.83M	2.58M	2.72M	3.08M	3.33M
OpEx % of Revenue	-	-	0.57%	0.39%	0.73%	0.82%	2.54%	1.47%	2.15%	2.52%
Selling, General & Admin	300K	75.36K	265.68K	607.36K	624.54K	2.83M	2.46M	2.72M	3.08M	3.33M
SG&A % of Revenue	-	-	0.55%	0.39%	0.73%	0.82%	2.42%	1.47%	2.15%	2.52%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	-14K	0	0	0	121.51K	0	0	0
Operating Income+	-300K	-75.36K	-366.96K	-514.51K	-532.77K	-158.13K	-1.86M	-1.53M	-2.15M	-2.57M
Operating Margin %	-	-	-0.75%	-0.33%	-0.62%	-0.05%	-1.83%	-0.83%	-1.5%	-1.95%
Operating Income Growth %	-	0.75%	-3.87%	-0.4%	-0.04%	0.7%	-10.75%	0.18%	-0.4%	-0.2%
EBITDA+	0	0	-132.88K	-353.37K	-677.87K	5.34K	-1.64M	-1.32M	-1.92M	-2.35M
EBITDA Margin %	-	-	-0.27%	-0.23%	-0.79%	0%	-1.61%	-0.71%	-1.34%	-1.77%
EBITDA Growth %	-	-	-	-1.66%	-0.92%	1.01%	-308.49%	0.2%	-0.46%	-0.22%
D&A (Non-Cash Add-back)	300K	75.36K	234.09K	161.14K	0	163.47K	217.21K	217.94K	223.19K	226.65K
EBIT	0	0	-234.09K	-131.17K	-677.87K	-158.13K	-1.86M	-1.53M	-2.15M	-2.57M
Net Interest Income+	0	0	0	0	0	0	25.57K	16.19K	29.25K	67.93K
Interest Income	0	0	0	0	0	0	25.57K	16.19K	29.25K	67.93K
Interest Expense	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	0	0	109.15K	-5.13K	-145.09K	674.48K	-529.04K	-136.87K	40.22K	92.23K
Pretax Income+	-300K	-75.36K	-124.94K	-519.64K	-677.86K	516.35K	-2.39M	-1.67M	-2.11M	-2.48M
Pretax Margin %	-	-	-0.26%	-0.34%	-0.79%	0.15%	-2.35%	-0.9%	-1.47%	-1.88%
Income Tax+	0	0	5.33K	0	0	161.58K	137.07K	-4.05K	3.58K	4.93K
Effective Tax Rate %	1%	1%	1.04%	1%	1%	0.69%	1.06%	1.01%	1%	1%
Net Income+	-300K	-75.36K	-130.27K	-519.64K	-677.86K	354.77K	-2.52M	-1.69M	-2.1M	-2.47M
Net Margin %	-	-	-0.27%	-0.34%	-0.79%	0.1%	-2.48%	-0.91%	-1.47%	-1.87%
Net Income Growth %	-	0.75%	-0.73%	-2.99%	-0.3%	1.52%	-8.12%	0.33%	-0.25%	-0.18%
Net Income (Continuing)	-300K	-75.36K	-130.27K	-519.64K	-677.86K	354.77K	-2.52M	-1.67M	-2.11M	-2.49M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	-336	20.51K	11.78K	-3.79K
EPS (Diluted)+	-0.00	-0.00	-0.00	-0.00	-0.00	0.00	-0.01	-0.02	-0.03	-0.63
EPS Growth %	-	-	-	-	-	-	-	-	-0.44%	-21.74%
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.00	0.00	-0.01	-0.02	-0.03	-0.63
Diluted Shares Outstanding	376.28M	376.28M	376.28M	376.28M	376.32M	376.39M	376.22M	87.82M	75.81M	63.49M
Basic Shares Outstanding	376.28M	376.28M	373.28M	376.28M	376.32M	376.39M	376.22M	87.82M	75.85M	63.49M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	10	2.31M	2.71M	3.79M	3.54M	5.68M	3.91M	2.03M	5.19M	2.78M
Cash & Short-Term Investments	10	2.31M	1.86M	2.86M	2.74M	3.52M	2.6M	1.44M	4.83M	2.04M
Cash Only	10	2.31M	1.86M	2.86M	238.94K	3.52M	622.5K	1.44M	4.83M	2.04M
Short-Term Investments	0	0	0	0	2.51M	0	1.98M	0	0	0
Accounts Receivable	0	0	489.84K	435.55K	523K	175.99K	1.29K	17.9K	66.99K	58.51K
Days Sales Outstanding	-	-	367.12	102.83	222.3	18.61	0.46	3.52	17.08	16.14
Inventory	0	0	0	0	0	589.81K	676.77K	46.28K	47.91K	46.35K
Days Inventory Outstanding	-	-	-	-	-	277.48	830.79	25.36	35.36	30.02
Other Current Assets	0	0	0	0	269.19K	0	0	0	0	0
Total Non-Current Assets+	0	0	1.33M	860.28K	798.62K	1.53M	812.41K	763.22K	559.34K	463.32K
Property, Plant & Equipment	0	0	0	0	0	692.45K	453.52K	223.28K	521.49K	435.01K
Fixed Asset Turnover	-	-	-	-	-	4.99x	2.24x	8.31x	2.74x	3.04x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	5.83K	3.66K	24.04K	17.46K	13.08K
Long-Term Investments	0	0	1.33M	860.28K	798.62K	578.53K	90.5K	16.69K	20.17K	15.24K
Other Non-Current Assets	0	0	0	0	0	249.53K	264.74K	499.2K	0	0
Total Assets+	10	2.31M	5.13M	4.65M	4.34M	7.21M	4.72M	2.79M	5.74M	3.24M
Asset Turnover	-	-	0.09x	0.33x	0.20x	0.48x	0.22x	0.67x	0.25x	0.41x
Asset Growth %	-	231273.8%	1.22%	-0.09%	-0.07%	0.66%	-0.34%	-0.41%	1.06%	-0.44%
Total Current Liabilities+	25K	8.1K	144.29K	71.4K	83.99K	1.04M	1.31M	1.23M	1.07M	1.12M
Accounts Payable	0	0	0	0	2.79K	0	13.71K	28.83K	90.43K	102.8K
Days Payables Outstanding	-	-	-	-	1.33	-	16.84	15.8	66.75	66.57
Short-Term Debt	0	0	0	0	3.95K	0	0	0	0	0
Deferred Revenue (Current)	0	0	0	0	0	236.13K	279.69K	363.02K	101.58K	96.98K
Other Current Liabilities	25K	0	7.19K	0	77.25K	0	0	-384.38K	0	0
Current Ratio	0.00x	285.52x	18.77x	53.10x	42.11x	5.47x	2.98x	1.65x	4.84x	2.48x
Quick Ratio	0.00x	285.52x	18.77x	53.10x	42.11x	4.91x	2.46x	1.61x	4.79x	2.44x
Cash Conversion Cycle	-	-	-	-	-	-	814.41	13.08	-14.3	-20.41
Total Non-Current Liabilities+	0	0	0	0	0	247.23K	99.06K	0	292.09K	190.78K
Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	241.49K	83.48K	0	292.09K	190.78K
Deferred Tax Liabilities	0	0	0	0	0	5.74K	15.57K	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0	0	0	0
Total Liabilities	25K	8.1K	144.29K	71.4K	83.99K	1.29M	1.41M	1.23M	1.36M	1.31M
Total Debt+	0	100	0	0	3.95K	395.76K	240.58K	82.71K	437.72K	362.78K
Net Debt	-10	-2.31M	-1.86M	-2.86M	-234.99K	-3.12M	-381.92K	-1.36M	-4.39M	-1.68M
Debt / Equity	-	0.00x	-	-	0.00x	0.07x	0.07x	0.05x	0.10x	0.19x
Debt / EBITDA	-	-	-	-	-	74.14x	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-584.83x	-	-	-	-
Interest Coverage	-	-	-	-	-	-	-	-	-	-
Total Equity+	-24.99K	2.3M	2.56M	4.58M	4.25M	5.92M	3.31M	1.56M	4.38M	1.93M
Equity Growth %	-	93.22%	0.11%	0.79%	-0.07%	0.39%	-0.44%	-0.53%	1.8%	-0.56%
Book Value per Share	-0.00	0.01	0.01	0.01	0.01	0.02	0.01	0.02	0.06	0.03
Total Shareholders' Equity	-24.99K	2.3M	2.56M	4.58M	4.25M	5.92M	3.31M	1.54M	4.37M	1.93M
Common Stock	10	37.13K	37.18K	37.63K	37.63K	37.65K	29.05K	7.54K	7.71K	399
Retained Earnings	-25K	-100.36K	-279.04K	-750.28K	-1.09M	-734.44K	-3.26M	-4.95M	-7.05M	-9.52M
Treasury Stock	0	0	0	0	0	0	0	0	-14	0
Accumulated OCI	0	0	3.74K	-79	9.79K	181.02K	93.4K	9.27K	30.21K	27.85K
Minority Interest	0	0	0	0	0	0	-336	20.51K	11.78K	-3.79K

Cash Flow

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	0	-100.26K	-347.98K	-667.06K	-113.94K	-557.95K	-845.84K	-811.68K	-2M	-2.73M
Operating CF Margin %	-	-	-0.71%	-0.43%	-0.13%	-0.16%	-0.83%	-0.44%	-1.4%	-2.06%
Operating CF Growth %	-	-	-2.47%	-0.92%	0.83%	-3.9%	-0.52%	0.04%	-1.47%	-0.36%
Net Income	-300K	-75.36K	-130.27K	-519.64K	-677.86K	354.77K	-2.52M	-1.67M	-2.11M	-2.49M
Depreciation & Amortization	0	0	0	0	0	163.47K	217.21K	217.94K	223.19K	226.65K
Stock-Based Compensation	0	0	0	0	0	0	0	0	0	0
Deferred Taxes	0	0	0	0	0	178.33K	10.13K	-14.75K	-220	220
Other Non-Cash Items	0	0	30.16K	474.55K	525.23K	-510.2K	644.05K	78.83K	24.71K	110.69K
Working Capital Changes	300K	-24.9K	-247.86K	-621.97K	156.59K	-744.32K	807.46K	572.38K	-139.57K	-577.74K
Change in Receivables	0	0	0	-511.61K	-85.6K	-167.57K	167.57K	21K	-45.67K	-21.51K
Change in Inventory	0	0	0	0	0	78.67K	192.71K	343.48K	-3.22K	-4.22K
Change in Payables	0	0	0	35.15K	-32.31K	-2.8K	0	41.42K	38.46K	39.55K
Cash from Investing+	0	0	-1.36M	-2.5K	-1.5K	1.28M	-3.96K	-32.12K	-17.25K	-50.05K
Capital Expenditures	0	0	0	0	0	-4.73K	-3.96K	-9.43K	-52.32K	-50.16K
CapEx % of Revenue	-	-	-	-	-	0%	0%	0.01%	0.04%	0.04%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	-1.36M	0	-1.5K	-178	0	-22.69K	35.07K	112
Cash from Financing+	120	2.41M	2.93M	-5.32K	-4.57K	-22.09K	-19.06K	-234.47K	5.4M	-11.86K
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	120	-2.36M	-2.92M	-5.32K	-4.57K	-22.09K	-19.06K	-234.47K	0	0
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	0	-100.26K	-347.98K	-667.06K	-113.94K	-562.86K	-849.8K	-843.8K	-2.05M	-2.78M
FCF Margin %	-	-	-0.71%	-0.43%	-0.13%	-0.16%	-0.84%	-0.45%	-1.44%	-2.1%
FCF Growth %	-	-	-2.47%	-0.92%	0.83%	-3.94%	-0.51%	0.01%	-1.43%	-0.35%
FCF per Share	-	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.01	-0.03	-0.04
FCF Conversion (FCF/Net Income)	-	1.33x	2.67x	1.28x	0.17x	-1.57x	0.34x	0.48x	0.95x	1.10x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	288.93K	326.84K	78.51K	34.84K	24K

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-6.61%	-5.35%	-14.55%	-15.35%	6.97%	-54.65%	-69.2%	-70.73%	-78.3%
Return on Invested Capital (ROIC)	-	-	-78.85%	-31.78%	-13.92%	-3.48%	-48.62%	-73.3%	-1669.61%	-1623.38%
Gross Margin	-	-	9.36%	7.07%	10.69%	77.53%	70.76%	64.13%	65.44%	57.39%
Net Margin	-	-	-26.75%	-33.61%	-78.94%	10.28%	-248.21%	-90.86%	-146.88%	-186.77%
Debt / Equity	-	0.00x	-	-	0.00x	0.07x	0.07x	0.05x	0.10x	0.19x
FCF Conversion	-	1.33x	2.67x	1.28x	0.17x	-1.57x	0.34x	0.48x	0.95x	1.10x
Revenue Growth	-	-	-	217.46%	-44.46%	302.06%	-70.55%	82.56%	-22.92%	-7.57%

Revenue by Segment

	2024
Product Health Therapies	913.3K
Product Health Therapies Growth	-
Health and Wellness Services	207.55K
Health and Wellness Services Growth	-
Energized Mineral Concentrate	43.49K
Energized Mineral Concentrate Growth	-
Ionized Cal Mag	388
Ionized Cal Mag Growth	-

Frequently Asked Questions

Growth & Financials

Agape ATP Corporation (ATPC) reported $1.5M in revenue for fiscal year 2024.

Agape ATP Corporation (ATPC) saw revenue decline by 7.6% over the past year.

Agape ATP Corporation (ATPC) reported a net loss of $2.7M for fiscal year 2024.

Dividend & Returns

Agape ATP Corporation (ATPC) has a return on equity (ROE) of -78.3%. Negative ROE indicates the company is unprofitable.

Agape ATP Corporation (ATPC) had negative free cash flow of $2.9M in fiscal year 2024, likely due to heavy capital investments.